tRNA-m 1 A modification promotes T cell expansion via efficient MYC protein synthesis
Yongbo Liu,Jing Zhou,Xiaoyu Li,Xiaoting Zhang,Jintong Shi,Xuefei Wang,Hao Li,Shan Miao,Huifang Chen,Xiaoxiao He,Liting Dong,Gap Ryol Lee,Junke Zheng,Ru-Juan Liu,Bing Su,Youqiong Ye,Richard A. Flavell,Chengqi Yi,Yuzhang Wu,Hua-Bing Li
DOI: https://doi.org/10.1038/s41590-022-01301-3
IF: 30.5
2022-09-23
Nature Immunology
Abstract:Naive T cells undergo radical changes during the transition from dormant to hyperactive states upon activation, which necessitates de novo protein production via transcription and translation. However, the mechanism whereby T cells globally promote translation remains largely unknown. Here, we show that on exit from quiescence, T cells upregulate transfer RNA (tRNA) m 1 A58 'writer' proteins TRMT61A and TRMT6, which confer m 1 A58 RNA modification on a specific subset of early expressed tRNAs. These m 1 A-modified early tRNAs enhance translation efficiency, enabling rapid and necessary synthesis of MYC and of a specific group of key functional proteins. The MYC protein then guides the exit of naive T cells from a quiescent state into a proliferative state and promotes rapid T cell expansion after activation. Conditional deletion of the Trmt61a gene in mouse CD4 + T cells causes MYC protein deficiency and cell cycle arrest, disrupts T cell expansion upon cognate antigen stimulation and alleviates colitis in a mouse adoptive transfer colitis model. Our study elucidates for the first time, to our knowledge, the in vivo physiological roles of tRNA-m 1 A58 modification in T cell-mediated pathogenesis and reveals a new mechanism of tRNA-m 1 A58-controlled T cell homeostasis and signal-dependent translational control of specific key proteins.
immunology